Agios Pharmaceuticals Inc
NASDAQ:AGIO
Agios Pharmaceuticals Inc
Revenue
Agios Pharmaceuticals Inc
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Agios Pharmaceuticals Inc
NASDAQ:AGIO
|
Revenue
$26.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-22%
|
CAGR 10-Years
0%
|
|
Abbvie Inc
NYSE:ABBV
|
Revenue
$54.3B
|
CAGR 3-Years
6%
|
CAGR 5-Years
11%
|
CAGR 10-Years
11%
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Revenue
$27.5B
|
CAGR 3-Years
2%
|
CAGR 5-Years
4%
|
CAGR 10-Years
7%
|
|
Amgen Inc
NASDAQ:AMGN
|
Revenue
$28.2B
|
CAGR 3-Years
4%
|
CAGR 5-Years
3%
|
CAGR 10-Years
4%
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Revenue
$9.9B
|
CAGR 3-Years
17%
|
CAGR 5-Years
26%
|
CAGR 10-Years
23%
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Revenue
$13.1B
|
CAGR 3-Years
16%
|
CAGR 5-Years
14%
|
CAGR 10-Years
20%
|
Agios Pharmaceuticals Inc
Revenue Breakdown
Breakdown by Geography
Agios Pharmaceuticals Inc
Breakdown by Segments
Agios Pharmaceuticals Inc
Total Revenue:
26.8m
USD
|
Product Revenue, Net:
26.8m
USD
|
See Also
What is Agios Pharmaceuticals Inc's Revenue?
Revenue
26.8m
USD
Based on the financial report for Dec 31, 2023, Agios Pharmaceuticals Inc's Revenue amounts to 26.8m USD.
What is Agios Pharmaceuticals Inc's Revenue growth rate?
Revenue CAGR 10Y
0%
Over the last year, the Revenue growth was 88%.